Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MDWD | US
0.37
2.23%
Healthcare
Biotechnology
30/06/2024
25/03/2026
16.98
16.86
17.37
16.79
MediWound Ltd. a biopharmaceutical company develops manufactures and commercializes novel bio-therapeutic and non-surgical solutions for tissue repair and regeneration in United States Europe and internationally. It markets NexoBrid a biopharmaceutical product for the removal of eschar a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005 which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne Israel.
View LessMicrocap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
34.7%1 month
31.0%3 months
39.5%6 months
37.8%-
-
10.93
-
-
-6.32
8.56
-0.07
-14.50M
183.15M
183.15M
-
-88.56
-
6.10
-75.66
13.70
6.28
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.22
Range1M
1.88
Range3M
3.45
Rel. volume
0.61
Price X volume
775.10K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| MONOPAR THERAPEUTICS | MNPR | Biotechnology | 56.95 | 200.49M | 3.08% | n/a | 0.00% |
| Centrexion Therapeutics Corporation | CNTX | Biotechnology | 2.67 | 200.25M | -16.04% | n/a | 0.00% |
| MacroGenics Inc | MGNX | Biotechnology | 3.17 | 198.83M | 16.12% | n/a | 58.90% |
| Verrica Pharmaceuticals Inc | VRCA | Biotechnology | 4.62 | 197.13M | 3.13% | n/a | -348.20% |
| Coherus BioSciences Inc | CHRS | Biotechnology | 1.77 | 195.91M | 3.51% | n/a | -354.71% |
| Abeona Therapeutics Inc | ABEO | Biotechnology | 4.42 | 191.45M | 2.08% | n/a | 31.63% |
| OABI | OABI | Biotechnology | 1.62 | 191.42M | -2.99% | n/a | 8.27% |
| Editas Medicine Inc | EDIT | Biotechnology | 2.32 | 191.35M | 3.11% | n/a | 16.68% |
| Arcturus Therapeutics Ltd | ARCT | Biotechnology | 7.06 | 190.92M | 6.17% | n/a | 11.94% |
| Lexeo Therapeutics Inc. Common Stock | LXEO | Biotechnology | 5.72 | 189.11M | 4.00% | n/a | 6.58% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CPI Card Group Inc | PMTS | Building Products & Equipment | 14 | 156.21M | -0.92% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 9.35 | 150.13M | 1.08% | n/a | 286.96% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.1 | 99.37M | 0.66% | 9.09 | 39.79% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.04 | 97.76M | -0.41% | 5.16 | 19.82% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 12.05 | 75.45M | 0.75% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 2.4499 | 44.25M | 13.94% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.44 | 21.04M | -6.49% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.559 | 10.80M | 3.33% | n/a | 58.43% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 3.7001 | 5.64M | 6.94% | n/a | 204.46% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.3644 | 3.47M | 5.62% | n/a | 19.98% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.32 | 0.53 | Cheaper |
| Ent. to Revenue | 8.56 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 10.93 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 39.50 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 183.15M | 3.66B | Emerging |